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Abstract
Background: Articular cartilage is a highly functional tissue which covers the ends of long bones and serves to ensure
proper joint movement. A tissue engineering approach that recapitulates the developmental characteristics of articular
cartilage can be used to examine the maturation and degeneration of cartilage and produce fully functional neotissue
replacements for diseased tissue.
Methodology/Principal Findings: This study examined the development of articular cartilage neotissue within a self-
assembling process in two phases. In the first phase, articular cartilage constructs were examined at 1, 4, 7, 10, 14, 28, 42,
and 56 days immunohistochemically, histologically, and through biochemical analysis for total collagen and
glycosaminoglycan (GAG) content. Based on statistical changes in GAG and collagen levels, four time points from the
first phase (7, 14, 28, and 56 days) were chosen to carry into the second phase, where the constructs were studied in terms
of their mechanical characteristics, relative amounts of collagen types II and VI, and specific GAG types (chondroitin 4-
sulfate, chondroitin 6-sulfate, dermatan sulfate, and hyaluronan). Collagen type VI was present in initial abundance and then
localized to a pericellular distribution at 4 wks. N-cadherin activity also spiked at early stages of neotissue development,
suggesting that self-assembly is mediated through a minimization of free energy. The percentage of collagen type II to total
collagen significantly increased over time, while the proportion of collagen type VI to total collagen decreased between 1
and 2 wks. The chondroitin 6- to 4- sulfate ratio decreased steadily during construct maturation. In addition, the
compressive properties reached a plateau and tensile characteristics peaked at 4 wks.
Conclusions/Significance: The indices of cartilage formation examined in this study suggest that tissue maturation in self-
assembled articular cartilage mirrors known developmental processes for native tissue. In terms of tissue engineering, it is
suggested that exogenous stimulation may be necessary after 4 wks to further augment the functionality of developing
constructs.
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Introduction
Articular cartilage is a specialized type of hyaline cartilage,
providing a nearly frictionless surface along diarthrodial joints and
acting to resist and distribute compressive forces. Its tensile and
compressive properties are attributed to the presence of fibrillar
collagens and negatively charged glycosaminoglycans (GAGs),
respectively, in the tissue’s extracellular matrix (ECM). Articular
cartilage lacks the ability to repair itself under conditions of wear and
tear or traumatic injury [1], leading to osteoarthritis (OA) which
afflicts millions of Americans and significantly affects the economy
[2]. In recent years, tissue engineering has become a promising
option toward the treatment of OA, allowing researchers to produce
functional replacements for diseased cartilage.
Toward this end, a self-assembling process has been developed
in our laboratory to yield cartilage tissue constructs of clinically
relevant dimensions and compressive mechanical properties
approaching those of native tissue [3–5]. Most notably, this
approach does not involve the use of a scaffold, thereby bypassing
the typical scaffold-related concerns of biodegradability, stress-
shielding, and hindrance of cell-to-cell communication. While
previous studies have focused on the end functionality of tissue
constructs, an understanding of the development of neotissue
within the self-assembling process remains incomplete. Studying
the maturation of these cartilage constructs will yield valuable
information regarding the developing biophysical environment of
chondrocytes and elucidate intervention windows for biochemical
or biomechanical stimulation.
An understanding of native articular cartilage development is of
particular importance, as it will provide essential benchmarks for
tissue growth in vitro. The various ECM components, and their
associated arrangement, can be used as indicators for the
effectiveness of a myriad of tissue engineering approaches,
including the self-assembling process, to recapitulate the different
stages of the developmental process of articular cartilage and
produce functional tissue constructs [6]. Native articular cartilage
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first involving the formation of an interzone region through
mesenchymal condensation at the future joint site, which then
separates in a perichondrium-like layer and an intermediate layer
consisting of softer tissues. Nascent cartilage begins to form with
the chondrogenesis of mesenchymal progenitor cells located at the
perichondrium regions and continues to develop until the
formation of growth plates, which become the primary source of
self-renewing, proliferating chondrocytes [7]. Like many muscu-
loskeletal tissues, the biochemical composition of articular cartilage
undergoes substantial changes during its development, reflected
particularly in modulating levels and spatial organization of
specific collagen and GAG types [8,9]. In particular, it has been
observed that collagen type VI plays an essential role in cartilage
development and the maintenance of the cellular microenviron-
ment [10,11]. Variations in chondroitin sulfation patterns may be
further indicative of matrix remodeling [12,13], and thus affect the
binding and activity of growth factors or cytokines within the tissue
matrix. Correlating with these biochemical alterations, the
compressive and tensile mechanical properties of articular
cartilage also change during fetal and adolescent tissue maturation
[14–17].
The purpose of this study was to examine the development of
tissue within a self-assembling process for articular cartilage.
Specific emphasis was placed on the relative levels of collagen
types II and VI, and chondroitin 4-sulfate (CS-4) and chondroitin
6-sulfate (CS-6), and mechanisms of cellular aggregation during
the early stages of neotissue development. We hypothesized that
the relative levels of specific collagens (types II and VI) and GAGs
(CS-4 and CS-6) would follow known developmental trends for
native articular cartilage. We further examined the temporal-
spatial relationship of collagen types II and VI to identify the
progression of a pericellular matrix (PCM) within the tissue.
Additionally, this study investigated the compressive and tensile
mechanical characteristics of the constructs, and their relationships
to changing biochemical properties.
Materials and Methods
This study was performed in two phases to examine tissue
development within the self-assembling process for articular
cartilage. In the first phase, tissue constructs were assessed
histologically and quantitatively for their total collagen and
GAG content after 1, 4, 7, 10, 14, 28, 42, and 56 days of
development. In the second phase, four time points from the first
phase (7, 14, 28, and 56 days) were chosen to examine maturing
structure – function relationships in the tissue. To this end, tensile
and compressive mechanical properties of the tissue constructs
were related to collagen and GAG levels. The specific types of
collagen (types II and VI) and GAGs (CS-4, CS-6, dermatan
sulfate, and hyaluronan) were further investigated to identify key
matrix developmental trends. The seeding and culture techniques
were the same for both phases of this study.
Cell isolation and seeding
Articular chondrocytes were isolated from the distal femur of 1
wk old male calves (Research 87 Inc., Boston, MA) less than 36 h
post slaughter, via an overnight digestion in 0.2% collagenase type
II (Worthington, Lakewood, NJ), as described previously [3]. To
reduce variability among animals, a mixture of cells were pooled
together from six and seven animals for the first and second phases
of the study, respectively, to yield a representative mixture of
chondrocytes. The pooled cells were counted on a hemocytom-
eter, and their viability was assessed using a trypan blue exclusion
test. Each femur yielded approximately 150 million chondrocytes
and a viability of .99% was determined for all specimens.
Chondrocytes were frozen in culture medium supplemented with
20% FBS and 10% DMSO at 280uC for 2 days before use. After
thawing, viability remained .80%. Chondrocytes were centri-
fuged at 1.2610
3 rpm for 7 min and resuspended at a density of
5.5610
7 cells/ml in a chemically-defined medium, consisting of
DMEM with 4.5 g/L-glucose and L-glutamine, 100 nM dexa-
methasone, 1% fungizone, 1% penicillin/streptomycin (Biowhit-
taker/Cambrex, Walkersville, MD), 1% ITS+ (BD Biosciences,
Bedford, MA), 50 mg/mL ascorbate-2-phosphate, 40 mg/mL L-
proline, and 100 mg/mL sodium pyruvate (Fisher Scientific,
Pittsburgh, PA). Articular cartilage constructs were seeded by
adding 100 ml of this cell suspension to custom-made 5 mm
agarose coated wells (described below). Time t=0 was defined as
this point of initial construct seeding. Cells were given 3 h to
coalesce and then a remaining 400 ml of medium was added to
each well. Medium was subsequently changed every 24 h. Based
upon prior results in our laboratory demonstrating enhanced tissue
mechanical properties [4], self-assembled constructs were removed
from confinement in the agarose well at 2 wks and transferred into
10-mm diameter wells coated with 2% agarose, where they
remained up to 8 wks.
Preparation of agarose wells for chondrocyte seeding
Agarose coated wells were constructed as described previously
[5,18]. Briefly, a negative polysulfone mold consisting of 5-mm
diameter610-mm long cylindrical prongs was constructed to fit
into 6 wells of a 48-well plate (Costar, Corning, NY). Individual
wells were constructed by pressing the negative mold into 1 ml of
sterilized, molten 2% molecular biology grade agarose in
phosphate-buffered saline (PBS) (Sigma, St. Louis, MO). The
agarose was allowed to gel at room temperature for 1 h with the
mold in place. To each agarose well, 500 ml of chemically-defined
medium was added and changed twice to saturate the well by the
time of cell seeding.
Histology and immunohistochemistry
Samples from both phases were frozen in cryoembedding
medium and sectioned at a thickness of 12 mm. Safranin-O and
fast green staining were used to visualize the GAG distribution
within the constructs [19]. Additional slides were processed for
qualitative immunohistochemistry (IHC) examination of the
presence and spatial arrangement of collagen type I, II, and VI,
using a Biogenex i600 autostainer (San Ramon, CA). After fixation
in 4uC acetone, the slides were washed with a solution of PBS
containing tween, quenched of exogenous peroxidase activity with
1% hydrogen peroxide in methanol and blocked with serum
(Vectastain ABC kit, Burlingame, CA). The slides were then
incubated with either mouse anti-collagen type I antibody (Axell,
Westbury, N.Y.) at a 1:750 dilution in PBS, rabbit anti- collagen
type II antibody (Cederlane, Burlington, NC) at a 1:500 dilution in
PBS, rabbit anti- collagen type VI antibody (US Biological,
Swampscott, MA) at a 1:300 dilution in PBS, or rabbit anti-
collagen type X antibody (Abcam Inc., Cambridge, MA) at a
1:300 dilution in PBS. The appropriate mouse or rabbit secondary
antibody (Vectastain ABC kit) was applied, followed by the avidin-
biotinylated enzyme complex (Vectastain ABC kit) and DAB
reagent (Vector Labs). Slides were removed from the autostainer,
counterstained with hematoxylin, dehydrated in graded ethanol,
and mounted with a coverslip. Slides stained without the addition
of a primary antibody served as negative controls. Native meniscal
fibrocartilage and articular cartilage served as positive controls for
collagen types I and II, respectively. The presence of N-cadherins
Engineered Tissue Development
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suspension. Briefly, slides were fixed in 4% paraformaldehyde,
blocked with 10% FBS, and incubated with a rabbit anti-N-
cadherin primary antibody (US Biological, Swampscott, MA) at a
1:240 dilution in 1% BSA in PBS, followed by detection with a
goat anti-rabbit secondary antibody (Alexaflour 546). Nuclei were
observed using a Hoescht’s stain. Porcine cardiac tissue served as a
positive control for N-cadherin immunohistochemistry.
Biochemical analysis
Approximately 3–4 mg pieces of each construct (n=6 per time
point) were frozen for biochemical analysis in both phases. Frozen
tissue pieces were lyophilized and digested in pepsin (10 mg/ml)
followed by pancreatic elastase (1 mg/ml) in acetic acid and Tris
buffer solutions, respectively. Total DNA content was measured by
Picogreen
H Cell Proliferation Assay Kit (Molecular Probes, Eugene,
OR). Total sulfated GAG was then quantified using the Blyscan
GAG assay kit (Biocolor, Newtownabbey, Northern Ireland), based
on the 1,9-dimethylmethylene blue binding [20,21]. Samples were
further assayed for total collagen content via hydrolysis in 2N
NaOH, followed by a chloramine-T hydroxyproline reaction, as
described previously [22]. Specific levels of collagen type II were
determined for Phase II samples using an Enzyme-Linked
ImmunoSorbent Assay (ELISA) assay, developed by Chondrex,
Inc. (Chondrex, Redmond, WA). Collagen type I was quantified via
a sandwich ELISA using a monoclonal mouse anti-human capture
antibody (USBiological) and polyclonal rabbit anti-human detection
antibody (USBiological).
The relative levels of collagen type VI were examined through
western blotting in Phase II. Based upon the results of the
hydroxyproline assay, the equivalent amount of each tissue digest
containing 20 mg of total collagen was precipitated for blotting. The
samples, collagen type VI protein standard, and a prestained SDS-
PAGE protein ladder (Bio-Rad) were loaded into a 10–20% Ready
Gel Tris-HCl Gel (Bio-Rad) and run at 50 mA for 30 min. The gels
were then transferred onto blotting paper at 350 mA for 60 min.
Blots wereblocked in2%BSA for 3 hatroomtemperatureand then
incubated with a rabbit anti-COL6 antibody (USBiological,
Swampscott, MA) at a 1:1500 dilution. A rabbit secondary antibody
(VectastainABCkit)wasapplied,followedbythe avidin-biotinylated
enzyme complex (Vectastain ABC kit) and DAB reagent (Vector
Labs) to visualize protein bands. The integrated optical density of
each band was determined using GelPro
H software (Media
Cybernetics, Bethesda, MD).
Fluorophore-assisted carbohydrate electrophoresis (FACE) anal-
ysis was additionally performed on Phase II samples (n=6) to
quantitatively determine changes in CS-4, CS-6, glucose,
dermatan sulfate, and hyaluronan during construct development,
as previously described [13,23,24]. Separate tissue construct
portions were frozen, lyophilized, and rehydrated in 100 mM
ammonium acetate. Tissue pieces were digested in 10% (w/v)
proteinase-K (EMD Pharmaceutical, Durham, NC) overnight at
60uC. Ammonium acetate (100 mM) was subsequently added to
each sample, and followed by digestion with either chondroitinase
AC II alone or together with chondroitinase ABC (Associates of
Cape Cod, Falmouth, MA). The difference in band intensity from
the two digests yielded dermatan sulfate content. Samples were
fluorescently tagged with with 2-aminoacridone HCl (Molecular
Probes, Eugene, Oreg., USA) and run on a carbohydrate
electrophoresis gel at 400 mA for 45–60 min. Individual FACE
gel bands were analyzed using GelPro
H software (Media
Cybernetics, Bethesda, MD). Specific GAGs and total glucose
were quantified via comparison to a fluorescently labeled
maltotriose standard curve.
Mechanical assessment
The compressive mechanical properties of Phase II samples
(n=6 per time point) were evaluated with an indentation
apparatus [25]. A 3-mm punch was extracted from each construct,
attached to the sample holder with cyanoacrylate glue, and
submerged in PBS. The sample was positioned under the load
shaft of the apparatus, such that the sample surface test point was
perpendicular to the indenter tip. A tare load of 0.2 g (0.002 N)
was applied using a 1-mm diameter rigid, flat-ended, porous
indenter tip and samples were allowed to reach tare creep
equilibrium. A step load of 0.7 g (0.007 N) was then applied and
sample displacement was measured until equilibrium was reached.
The intrinsic mechanical properties of the samples, aggregate
modulus (HA), permeability (k), and Poisson’s ratio (u), were
determined using the linear biphasic theory [26,27].
Tensile tests were performed on Phase II samples (n=6) with an
electromechanical materials testing system (Instron Model 5565,
Canton, MA) using a 50 N load cell. Samples were cut into a dog-
bone shape with an approximate gauge length of 1.5-mm and glued
ontopapertabsforgripping.Thethicknessandwidthofeachsample
were appropriately measured to calculate the cross sectional area for
the applied forces. Samples were pulled at a constant strain rate of
0.01 s
21. Stress-strain curves were developed from the load-
displacement curve and analyzed for the tissue’s tensile Young’s
modulus (EY) and ultimate tensile strength (UTS).
Statistical analysis
A single factor ANOVA was used with a Tukey’s post-hoc when
warranted.Significancewasdefinedasp,0.05throughoutthestudy.
Results
Based upon statistical changes in total collagen/wet weight
(WW) and GAG/WW levels within the constructs in Phase I, the
following four time points were selected for further investigation in
Phase II: Day 7, Day 14, Day 28, and Day 56.
Gross appearance
The physical characteristics of self-assembled engineered
articular cartilage constructs followed similar trends in develop-
ment during both experimental phases (Table 1). At day 1,
constructs appeared non-uniform and did not have smooth
surfaces. Beginning at day 7, the surfaces of the construct began
to glisten, suggesting an increased hydration and presence of
GAGs (Fig. 1). This glistening appearance consistently became
more evident over time. Finally, from 4 wks onward, the tissue
constructs took on a very slight ‘‘bowl shaped’’ morphology.
Histology and immunohistochemistry
The spatial arrangement of GAGs and collagen type II and VI
was modulated throughout the course of neotissue development
(Fig. 1). Safranin-O staining for GAGs was observed in a
pericellular distribution initially, with the staining intensity
increasing over time throughout the construct. Collagen type II
appeared evenly distributed within the ECM, with its staining
intensity increasing uniformly over time. Interestingly, collagen
type VI staining was observed in abundance initially throughout
the tissue matrix and then could be seen localized around
individual cells by 4 wks. Based on IHC, there was no collagen
types I or X production at any time point, indicating no cellular
dedifferentiation or hypertrophy in the constructs. Additionally,
N-cadherin staining demonstrated a minimal presence of the
protein in cell suspension. During the first day, however, the
intensity of N-cadherin staining increased drastically and peaked
Engineered Tissue Development
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onwards of 2 wks. Similar histology pictures could be seen for
Phase II (not shown) as was observed for Phase I.
Biochemical analysis
In the first phase, an increasing trend for GAG/WW was
observed, with statistically significant increases occurring between
days 7 and 14, days 14 and 28, and days 28 and 56. The GAG/WW
values were 1.060.6%, 1.360.4%, 1.960.2%, 2.160.7%,
3.560.8%, 7.561.1%, 8.261.2%, and 9.160.3%, at days 1, 4, 7,
10, 14, 28, 42, and 56, respectively. Total GAG per construct also
increased during tissue development, attaining a maximum value of
3.260.2 mg at 8 wks. In contrast to GAG/WW, a decreasing trend
was found for total collagen/WW, with statistically significant
changes between days 28 and 56. However, total collagen per
constructdisplayed an increasing trend over time reaching a value of
1.960.3 mg at 8 wks. The collagen/WW values were 19.066.2%,
19.064.4%, 18.164.4%, 12.562.4%, 12.062.7%, 9.662.1%,
6.560.9%, and 5.360.9%, at days 1, 4, 7, 10, 14, 28, 42, and 56,
respectively (Fig. 2). There were no statistical differences in construct
cellularity during neotissue maturation.
Further investigation in Phase II into the specific levels of
collagens type II and VI exposed differing trends. Through ELISA
quantification, the levels of collagen type II/WW were 0.760.2%,
1.460.1%, 3.960.1%, and 4.960.7% for 1, 2, 4, and 8 wks,
respectively, with statistical differences between 2 and 4 wks, and 4
and 8 wks. When normalized to total collagen, percentages of
collagen type II to total collagen were 8.162.0%, 13.863.0%,
42.363.9%, and 69.1612.9% for 1, 2, 4, and 8 wks, respectively
(Fig. 3). Statistical changes were observed between 2 and 4 wks,
and 4 and 8 wks. Through western blotting, the proportion of
collagen type VI to total collagen also changed during develop-
ment (Fig. 3). In the example blot, the integrated optical density of
the band decreased by approximately 40% between 1 and 2 wks.
No change was observed between 2 and 4 wks, and a 15% increase
in band density occurred between 4 and 8 wks. Similar trends were
observed in all samples tested. Collagen type I was not detectable
at any time point with the ELISA.
Examination into the specific GAGs in Phase II samples
revealed a decreasing ratio of CS-6 to CS-4 over time (Fig. 3). At
1, 2, 4, and 8 wks the relative levels of CS-6 to CS-4 was 2.560.4,
2.160.2, 1.860.1, and 1.460.3, respectively. Statistical differenc-
es were observed between 1 and 4 wks, 1 and 8 wks, and 2 and 8
wks. The total amount of chondroitin (0-, 4-, and 6-) sulfate was
further quantified to display an increasing molar concentration
over time. The total chondroitin sulfate values were 7.464.5
nmol/mg, 36.467.3 nmol/mg, 48.4612.6 nmol/mg, and
64.565.3 nmol/mg for 1, 2, 4, and 8 wks, respectively, and
statistical increases were recorded between 1 and 2 wks and 4 and
8 wks. Conversely, the total dermatan sulfate levels were 1.461.3
nmol/mg, 4.263.6 nmol/mg, 7.563.1 nmol/mg, and 5.361.7
nmol/mg for 1, 2, 4, and 8 wks, respectively, with a statistical
difference observed only between 1 and 4 wks. Moreover, the
amount of glucose in each sample was 0.260.2 nmol/mg, 0.660.2
nmol/mg, 3.161.1 nmol/mg, and 3.160.9 nmol/mg at 1, 2, 4,
and 8 wks, respectively, with a statistical increase observed
between 2 and 4 wks. Finally, hyaluronan was not observed in a
measurable quantity at any time point.
Figure 1. Gross morphology (column 1) and histological
sections (columns 2–4) of self-assembled cartilage constructs.
Original magnification, 40X. GAGs were initially concentrated pericellu-
larly, but were observed throughout the tissue by 4 wks. Also at 4 wks,
collagen type VI localized around the cells, while collagen type II
appeared evenly distributed in the constructs.
doi:10.1371/journal.pone.0002795.g001
Table 1. Physical characteristics of self-assembled articular
cartilage constructs.
Phase I Wet Weight (mg) Thickness (mm) Diameter (mm)
Day 1 4.262.8 0.460.1 5.060.2
Day 4 6.761.3 0.460.1 5.260.3
Day 7 7.061.3 0.460.1 5.560.2
Day 10 8.961.0 0.560.1 5.360.2
Day 14 10.161.1 0.560.1 5.360.2
Day 28 15.962.7 0.660.2 5.960.2
Day 42 25.763.7 0.660.2 6.360.1
Day 56 35.961.8 0.860.2 7.360.1
Phase II
Week 1 5.660.4 0.360.1 5.060.2
Week 2 8.960.5 0.460.1 5.060.1
Week 4 18.660.8 0.660.1 5.960.1
Week 8 34.365.8 0.860.1 7.160.2
doi:10.1371/journal.pone.0002795.t001
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between 7 and 14 days, 14 and 28 days, and 28 and 56 days (A). Significant differences can be observed in collagen/WW between 7 and 14 days, and
28 and 56 days (B). Increasing trends were observed for both total GAG per construct (C) and total collagen per construct (D). Data presented as
mean6standard deviations.
doi:10.1371/journal.pone.0002795.g002
Figure 3. Three major biochemical changes can be observed in cartilage neotissue maturation with the self-assembling process,
which mirror known developmental trends for articular cartilage. (A) The percentage of collagen type II to total collagen increased
consistently over time, from 8.1% at 1 wk to 69.1% at 8 wks, with statistically significant increases between 2, 4, and 8 wks. (B) In a western blot for
collagen type VI, normalized to total collagen content, it is observed that at the proportion of collagen type VI to total collagen decreased by
approximately 40% between 1 and 2 wks and then increased slightly at 8 wks. Relative collagen type VI levels were determined by the integrated
optical density of each band. (C) The ratio of CS-6 to CS-4 decreased steadily during construct maturation, from 2.4 at 1 wk to 1.4 at 8 wks. Data
presented as mean6standard deviations.
doi:10.1371/journal.pone.0002795.g003
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trends for total GAG and collagen as the first phase (Fig. 4). The
GAG/WW levels were 2.460.3%, 5.960.2%, 9.460.7%, and
10.060.1% for 1, 2, 4, and 8 wks, respectively. Statistical changes
were observed for GAG/WW between 1 and 2 wks, and 2 and 4
wks. The collagen/WW levels were 8.961.0%, 10.061.6%,
9.460.9%, and 6.961.0% at 1, 2, 4, and 8 wks, respectively. A
statistically significant drop in collagen/WW was observed
between 4 and 8 wks.
Mechanical assessment
The compressive and tensile properties of the constructs were
assessed in Phase II (Fig. 4). The aggregate modulus of the
constructs was 37.2615.2 kPa, 85.7619.4 kPa, 280.3652.7 kPa,
and 304.0672.6 kPa, for 1, 2, 4, and 8 wks, respectively, with a
statistically significant increase between 2 and 4 wks. A significant
linear correlation (R
2=0.96, p,0.05) was further observed
between the mean aggregate modulus and GAG/WW of each
group. The permeability of the constructs was 1.561.9 (610
215)
m
4/N-s, 8.567.5 (610
215)m
4/N-s, 6.065.8 (610
215)m
4/N-s,
and 11.064.5 (610
215)m
4/N-s at 1, 2, 4, and 8 wks, respectively.
A significant difference in permeability was observed between 1
and 8 wks. The Poisson’s ratio of the constructs also increased over
time, with values of 0.160.1, 0.260.1, 0.360.1, 0.460.1 at 1, 2, 4,
and 8 wks, respectively. Significant changes in Poisson’s ratio were
observed between 1 and 4 wks, 1 and 8 wks, and 2 and 8 wks.
The Young’s modulus of the 4 wk constructs at 1035.4696.4 kPa
was statistically greater than any other time point. The ultimate
tensile strength of the 2 and 4 wk constructs at 293.5655.3 kPa and
342.7652.3 kPa, respectively, were significantly different from the 1
and 8 wk groups at 143.4638.7 kPa and 200.3651.1 kPa,
respectively. Univariate regression analysis revealed that total
collagen/WW did not have a statistically significant relationship
with either the ultimate tensile strength (R
2=0.29, p=0.46) or the
Young’s modulus (R
2=0.001, p=0.97) of each group. Similarly,
collagen type II/WW was not statistically correlated to the Young’s
modulus (R
2=0.49, p=0.30) or the ultimate tensile strength
(R
2=0.10, p=0.68) at each time point.
Discussion
This study was designed to examine the maturation of neotissue
within a self-assembling process to engineer articular cartilage over
an 8 wk culture period. It is important to understand neotissue
development, since this may elucidate potential intervention
windows for biochemical or biomechanical stimulation, as well
as provide an essential characterization of structure and function
of tissue replacements. This study presents several notable findings
pertaining to the self-assembling process. 1) We demonstrate that
collagen type VI is present throughout the ECM at early stages of
neotissue growth and then localizes to a PCM around 4 wks,
thereby recapitulating a major characteristic of in vivo cartilage
development [8]. 2) Our results suggest that the initial cellular
aggregation and construct formation within the self-assembling
process is mediated by cadherin-cadherin interactions. 3) The
protein content for collagens type II and VI, and relative levels of
CS-4 and CS-6, follow similar trends to that of native cartilage
development during all 8 wks of culture. Similarly, tissue
compressive and tensile mechanical properties mirrored develop-
mental trends during the first 4 wks. 4) This study identifies 4 wks
as a potential time point for exogenous stimulation to further
augment the functional properties of the tissue constructs.
To our knowledge, this is the first study to demonstrate the
localization of collagen type VI in a scaffold-less tissue engineering
approach. Previous research has identified the protein in tissue
engineered cartilage scaffolds [28], and chondrocyte-seeded agarose
constructs [29], but not in a self-assembly cell-based approach which
seems to capture the developmental nature of articular cartilage.
Collagen type VI is the primary marker for the PCM [30,31]. The
PCM, together with its enclosed cell, is defined as the chondron and is
considered to be the smallest metabolic and functional unit of
articular cartilage [32]. In particular, it is known that the PCM
surrounding the chondrocyte organizes and constructs collagen
fibrils [32], regulates cellular osmolarity [33,34], and modulates
growth factor interactions with the enclosed cell [35]. The PCM also
acts as a biomechanical buffer of applied stresses [36–39] and may
play an important role in the mechanotransductive response of
chondrocytes to exogenous stimulation within a tissue engineering
Figure 4. Biomechanical and biochemical properties of the constructs in Phase II. Large and significant increases in the aggregate moduli
(A) were observed between 2 and 4 wks, corresponding to increases in GAG/WW (B). The Young’s modulus and ultimate tensile strength (C) increased
during the first 4 wks, coinciding with increases in the percentage of collagen type II to total collagen. Both tensile mechanical properties then
decreased significantly at 8 wks, concurrent with a similarly significant decrease in total collagen/WW (D). Data presented as mean6standard
deviations.
doi:10.1371/journal.pone.0002795.g004
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three-dimensional structure of chondrons [40] in self-assembled
cartilage constructs to further characterize the chondrocyte’s
developing microenvironment. In addition, chondrons can be
isolated from cartilage constructs at various stages of development
and directly tested to determine the mechanical properties of the
newly-formed PCM [38,41].
We propose that the early stages of tissue development within the
self-assembling process are mediated by cadherin-cadherin interac-
tions,asdescribedbythedifferentialadhesionhypothesis[42].These
interactions act to minimize the free energy of the population of cells
by sorting cells with varying intracellular adhesiveness. In articular
cartilage, it has been shown that N-cadherin activity spikes to its
highest level during mesenchymal condensation [43] and subse-
quently decreases around the central condensation region, as the
cells spread apart and begin to differentiate into chondrocytes. At
later stages of joint development, N-cadherin staining is only evident
in the perichondrium and not in mature cartilage tissue [44]. A
similar trend is observed in the maturation of self-assembled
engineered cartilage, suggesting that our process captures this
integral component of native articular cartilage development. N-
cadherins are minimally present in the initial cell suspension, and
then are observed with an intense staining upon 1 day of seeding.
Therefore, it can be inferred that N-cadherin activity plays a
significant role in cellular aggregation during the self-assembling
process. Indeed, this may have broad implications for future tissue
engineering studies attempting to recapitulate the zonal architecture
of various cartilaginous tissues through co-cultures of cells with
varying cadherin levels.
Parallel trends in collagen content can be observed in the
maturation of tissue within the self-assembling process and native
articular cartilage development. In our study, collagen type II
represented a small fraction (8%) of the total collagen at early
stages of neotissue maturation. Over time, collagen type II levels
significantly increased, reaching 69% of the total collagen at 8 wks.
Similarly, collagen type II is not found in native tissue until after
partuition, both in terms of mRNA expression or protein
production [45]. In mature cartilage, however, collagen type II
is observed throughout the ECM [8,45] and composes approxi-
mately 85–90% of the total collagen [46]. It was further observed
in this study that collagen type VI was present in high abundance
initially, and then decreased in proportion to total collagen, as the
protein localized around individual cells. An analogous trend has
been observed in native articular cartilage for collagen type VI.
The expression of collagen type VI spikes at chondrocyte
differentiation [10] and is present throughout matrix development
[8,11]. This steep rise in collagen type VI expression in native
tissue soon levels off at later stages of chondrogenesis, coinciding
with an upregulation in collagen type II [10].
In terms of chondroitin sulfate, there are several similarities
between the self-assembling process and native tissue maturation.
The decreasing ratio of CS-6 to CS-4 (from 2.5 at 1 wk to 1.4 at 8
wks) observed in this study is mirrored in native cartilage tissue
development. During embryogenesis, CS-6 can be found through-
out the developing matrix, then from parturition onwards the
staining intensity and relative abundance for the GAG increase
uniformly [9]. Conversely, CS-4 is observed in trace amounts in
the developing ECM [9], and then increases in content at a greater
rate than CS-6 post parturition [47,48]. However, it should be
noted that species dependant sulfation patterns have been
previously reported in developing tissues [49].
Similar trends can also be drawn between the maturing
biomechanical properties of self-assembled articular cartilage and
those of native tissue. Excitingly, this study observed analogous
trends in compressive mechanical properties to reported results in
the aggregate moduli of developing bovine articular cartilage. Our
2 wk (85619 kPa), 4 (280652 kPa), and 8 wk (304672 kPa)
values are right on par with the aggregate moduli of third trimester
fetal (110630 kPa), 1–3 wk old calf (270620 kPa), and young
adult bovine (310630 kPa) articular cartilage explants, respec-
tively, from the knee joint [16]. However, previous studies have
shown that the stiffness of mature bovine cartilage, as measured by
creep indentation, ranges from 472 kPa to 899 kPa [27,50],
suggesting that further increases in the compressive properties of
self-assembled articular cartilage constructs may be necessary.
Additional comparisons can be made between the changes in the
emergent tensile properties of self-assembled cartilage constructs and
the developing cartilage from the femoral condyle. Significant
increases in the Young’s moduli of our constructs between 2 and 4
wks and decreases between 4 and 8 wks mirrored the changes
observed between third trimester fetal, 1–3 wk old calf, and young
adult bovine articular cartilage [17]. These similarities in compres-
sive and tensile properties are additionally noteworthy since our
current study utilized immature bovine articular chondrocytes in the
self-assembling process. Taken together with the observed trends in
biochemical components, our results suggest that the self-assembling
process embodies many of the known developmental characteristics
for articular cartilage. Future studies, therefore, should look to
identify key developmental signaling patterns, such as Wnt [51,52]
orbonemorphogeneticproteinexpression[53],toconfirmthistissue
engineering approach as an appropriate model for in vitro cartilage
development. Moreover, further research may examine matrix
maturation during self-assembly of differentiated embryonic stem
cells [54], which more closely resemble the phenotypic state of cells
during the mesenchymal condensation phase of native articular
cartilage development.
Statistically significant changes in the developing compressive
and tensile mechanical properties of the neotissue were generally
accompanied by concurrent alterations in GAG and collagen
levels, respectively. Significant increases in GAG/WW between 1
wk (2.4%), 2 wk (5.9 %), and 4 wk (9.4%) coincided with a
stiffening of the constructs (37.2 kPa to 85.7 kPa to 280.3 kPa).
Moreover, a significant correlation was observed between GAG
levels and aggregate moduli. Notably however, no change was
observed in the aggregate modulus or GAG content after 4 wks,
although the Poisson’s ratio did continue to increase. This suggests
that other ECM components, possibly cross-linking proteins
collagen type IX or fibronectin, may influence the apparent
compressibility of the constructs, and thus warrant further
investigation. Similar relationships were observed between tensile
properties and collagen content. Statistically greater ultimate
tensile strength values at 2 and 4 wks (293.5 kPa and 342.7 kPa,
respectively) over 1 and 8 wks (143.4 kPa and 200.3 kPa,
respectively) followed similar trends in total collagen/WW. The
statistically significant decrease in total collagen/WW between 4
and 8 wks also coincided with a significant drop in Young’s moduli
(1035.4 kPa to 537.9 kPa). The significant increase in Young’s
modulus between 2 and 4 wks, however, was not accompanied by
changes in total collagen/WW. Therefore, it is possible that the
observed tensile stiffening may be due to collagen organizational
changes or increased cross-linking within the ECM. Additionally,
this difference in tensile properties may be accounted for by an
increased presence of collagen type II. Similarly, significant
increases in Young’s moduli and collagen type II/WW were
observed between 2 and 4 wks, indicating that the specific type of
collagen, not just total collagen content, present in the neotissue
may dramatically influence tensile properties. Moreover, this result
confirms the substantial role that collagen type II has on tensile
Engineered Tissue Development
PLoS ONE | www.plosone.org 7 July 2008 | Volume 3 | Issue 7 | e2795characteristics [55], and therefore a preferred target for growth
factor treatments to augment these properties [56].
Examining the structural and biochemical changes during tissue
construct growth within the self-assembling process sheds light on
potential intervention strategies employing exogenous stimulation.
At 4 wks, the GAG content of our constructs (9.4% GAG/WW) far
exceeds that of native tissue (,5% GAG/WW) [46]. While it is
important not to hinder the developing compressive properties, the
application of small doses of chondroitinase-ABC [57] or other
treatments may be helpful to reorganize the tissue matrix and bring
GAG levelscloser tothose ofnative tissue.Thisis essential for later in
vivo work where a mismatch between the osmolarity of the constructs
and the surrounding host tissue is undesirable. Potential mechanical
stimulation windows can also be identified. Our current finding of
PCM formation after 4 wks of growth suggests that this is potentially
an appropriate time point for compressive mechanical stimulation,
since the PCM is known to appropriately facilitate the transmission
of mechanical stresses onto the enclosed chondrocytes [36,39,58].
Moreover, our observation that the aggregate modulus reached a
plateau at 4 wks, and the tensile Young’s modulus decreased after 4
wks further warrants consideration that exogenous stimulation
mechanisms may be necessary around that time point to further
augmentthefunctionalcharacteristicsoftheneotissue.Thestatistical
dropintotalcollagen/WWbetween4 and 8wks,coincidingwiththe
decrease in tensile properties, is possibly due to increased activity of
matrix metalloproteinases, and thus, exogenous tissue inhibitor of
matrix metalloproteinases may be incorporated during this time
period to prevent further breakdown of the collagen matrix. The
slight increase in collagen type VI to total collagen between 4 and 8
wks may also signify greater matrix catabolism [59]. Moreover, the
lack of hyaluronan production at any time point suggests that GAGs
in our constructs are not being integrated into aggrecan aggregates,
which is likely essential for a continued increase in compressive
mechanical properties beyond 4 wks. Therefore, future studies
should consider mechanisms to initiate hyaluronan production, such
as hypoxia [60], growth factor stimulation [61], or inducible
overexpression systems [62]. Finally, a significant increase in glucose
retention was observed in the constructs between 2 and 4 wks, with
no change thereafter. This drop in glucose consumption could be
indicative of a concomitant decrease in chondrocyte metabolic
activity during this period, which may necessitate dynamic
mechanical stimulation [63] or greater concentrations of ascorbic
acid added to the culture medium [64] at 4 wks.
In conclusion, the development of neotissue within the self-
assembling process can be described in four phases (Fig. 5). In the
first phase, cells are seeded at a high density in a non-adherent
agarose mold. Minimal N-cadherin activity is present at this stage,
as the cells have not yet begun to recognize each other. In the
second phase, N-cadherin activity increases, suggesting greater
cell-cell interactions. According to the differential adhesion
hypothesis, cells begin to coalesce at this stage to minimize the
free energy within the biological system. In the third phase, cells
begin to migrate apart and produce an ECM consisting of
primarily collagen type VI, a known developmental marker, for
Figure 5. Tissue development within the self-assembling process can be described in four phases. In the first phase, a high density cell
suspension is seeded in an agarose mold. In the second phase, chondrocytes begin to recognize each other and coalesce through a minimization of
the free energy in the system, as described by the differential adhesion hypothesis. In the third phase, tissue constructs begin to form as the cells
migrate apart and secrete predominately collagen type VI and CS-6 to compose its extracellular matrix. In the fourth phase, extracellular matrix
separations become apparent, as indicated by a PCM surrounding individual chondrocytes. The initially abundant collagen type VI decreases in
proportion to total collagen and localizes around individual cells, as the percentage of collagen type II to total collagen increases. The mature tissue
matrix consists predominately of collagen type II and a slightly greater percentage of CS-6 than CS-4.
doi:10.1371/journal.pone.0002795.g005
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within the ECM can be identified, with notable differences in the
spatial distribution of collagen types II and VI. The mature tissue
matrix consists predominately of collagen type II, while collagen
type VI decreases in proportion to total collagen and presumes a
pericellular localization. In addition, the chondroitin sulfation
patterns change during neotissue development, as the CS-6 to CS-
4 ratio follows a downward trend over time. The composition of
this ECM can be directly related to the emergent compressive and
tensile mechanical properties of the neotissue.
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